PepGen (PEPG) Shares Outstanding (2021 - 2026)

PepGen (PEPG) posted Shares Outstanding (Entity) of $69.2 million for Q1 2026, up 63.82% sequentially from $42.2 million in Q4 2025, and up 111.39% YoY from $32.7 million in Q1 2025.

PepGen (PEPG) Shares Outstanding (2021 - 2026) Analysis & Trends

PepGen has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $69.2 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 111.39% year-over-year to $69.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.2 million (up 111.39% YoY) and the FY2025 annual result came in at $42.2 million, up 29.44% from the prior year.
  • Shares Outstanding (Entity) rose to $69.2 million in Q1 2026 per PEPG's latest filing, from $42.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $69.2 million in Q1 2026 and troughed at $963588.0 in Q1 2022.
  • A 5-year average of $28.9 million and a median of $32.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) surged 2535.44% in 2022, then increased 0.77% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $15.6 million in 2022, then surged by 52.33% to $23.8 million in 2023, then jumped by 36.92% to $32.6 million in 2024, then climbed by 29.44% to $42.2 million in 2025, then surged by 63.82% to $69.2 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $69.2 million, $42.2 million, and $34.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.19 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.45 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 445.06 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.61 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 PepGen 207.09 Mn 207.09 Mn - 69.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 69.20 Mn
Mar 31, 2026 69.09 Mn
Dec 31, 2025 42.22 Mn
Sep 30, 2025 34.36 Mn
Jun 30, 2025 32.75 Mn
Mar 31, 2025 32.67 Mn
Dec 31, 2024 31.58 Mn
Sep 30, 2024 32.58 Mn
Jun 30, 2024 32.47 Mn
Mar 31, 2024 28.66 Mn
Dec 31, 2023 23.80 Mn
Sep 30, 2023 23.79 Mn
Jun 30, 2023 23.79 Mn
Mar 31, 2023 23.76 Mn
Dec 31, 2022 15.64 Mn
Sep 30, 2022 23.56 Mn
Jun 30, 2022 14.09 Mn
Mar 31, 2022 963,588.00
Dec 31, 2021 901,108.00
Sep 30, 2021 894,060.00